Showing results (1301-1310 of 1,333) with videos related to
Sort By:
Pageof 134
Nature|November 4, 2014
The contribution of de novo coding mutations to autism spectrum disorderIvan Iossifov, Brian J O'Roak, Stephan J Sanders, et al.Allergy|February 14, 2008
The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantificationR van Ree, M D Chapman, F Ferreira, et al.Lupus|September 19, 2009
Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and PortugalB A Pons-Estel, J Sánchez-Guerrero, J Romero-Díaz, et al.The Journal of Allergy and Clinical Immunology|April 30, 2026
Clinical features, genetics, treatment, and long-term outcomes of STAT3 hyper-IgE syndrome: a single-center cohort analysisAlexandra F Freeman, Chen Wang, Amanda Urban, et al.Journal of the Pediatric Infectious Diseases Society|August 10, 2021
Comparative Effectiveness of Echinocandins vs Triazoles or Amphotericin B Formulations as Initial Directed Therapy for Invasive Candidiasis in Children and AdolescentsBrian T Fisher, Theoklis E Zaoutis, Rui Xiao, et al.Journal of the Pediatric Infectious Diseases Society|August 17, 2023
Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal NetworkRachel L Wattier, Robert F T Bucayu, Craig L K Boge, et al.Transplantation|July 31, 2025
Further Personalizing Medicine in Immune Disorders: Genomic Findings and Hematopoietic Cell Transplantation SurvivalMorgan N Similuk, Sarah A Bannon, Jia Yan, et al.The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 26, 2023
Clinical standards for drug-susceptible TB in children and adolescentsS S Chiang, S M Graham, H S Schaaf, et al.Nature Medicine|January 15, 2026
CD4<sup>+</sup> T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapyMatthew Ho, Luca Paruzzo, Julia Han Noll, et al.Nature Medicine|January 20, 2025
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapiesJulie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, et al.Pageof 134